Related Experiment Video
Updated: May 9, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
How equipped are pharmacists for pharmacogenomics?: A cross-sectional study on knowledge, attitudes, and
1Department of Clinical Pharmacy, College of Pharmacy, Taif University, Taif, Saudi Arabia.
Abstract:
Pharmacogenomics, the study of genetic influences on drug response, advances personalized medicine by tailoring therapy to individual genetic profiles, reducing adverse effects and optimizing efficacy. Pharmacists, as accessible healthcare providers, are well-positioned to facilitate the integration of pharmacogenomics into clinical practice. This study assesses Saudi pharmacists' knowledge, attitudes, and practices regarding pharmacogenomics and identifies key barriers and facilitators affecting their readiness. A cross-sectional survey was conducted between July and October 2024 among 426 licensed pharmacists across various practice settings in Saudi Arabia: a validated, structured questionnaire assessed demographics, pharmacogenomics knowledge, attitudes, and implementation practices. Snowball sampling facilitated participant recruitment. Descriptive statistics summarized the findings, and Chi-square tests were applied to examine associations between socio-demographic variables and pharmacogenomics-related responses. Among 426 participants, while most pharmacists recognized the value of pharmacogenomics, knowledge gaps were notable, particularly in interpreting genetic tests and applying clinical recommendations. Only 52.3% received pharmacogenomics training, mainly through university courses, and 40.6% had never consulted pharmacogenomics resources in practice. Key barriers included limited access to genetic testing (74.2%) and lack of reimbursement (64.5%). Socio-demographics, such as age and practice setting, significantly impacted knowledge and attitudes. Saudi pharmacists face considerable barriers to pharmacogenomics readiness, including knowledge gaps, limited access to genetic testing, and insufficient institutional support. Addressing these challenges requires targeted education, structured policy initiatives, and enhanced resource availability to facilitate the effective integration of pharmacogenomics into pharmacy practice. Strengthening pharmacists' competencies in this field will be essential to optimizing patient care and advancing precision medicine in Saudi Arabia.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Analysis of Population Pharmacokinetic Data
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Prodrugs
Prodrugs help overcome...
Biopharmaceutics and Pharmacokinetics: Overview

